Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2016 Jun 29;152(3):847–859. doi: 10.1016/j.jtcvs.2016.06.040

TABLE 1.

Preoperative and intraoperative patient characteristics

Variable* Normal (n = 21) Nonrecurrent IMR (n = 37) Recurrent IMR (n = 13)
Age, y 66.1 ± 14.4 68.0 ± 9.0 62.5 ± 13.0
Female 8 (38) 11 (30) 6 (46)
Body mass index, kg/m2 32.2 ± 8.0 28.5 ± 4.4 29.4 ± 6.5
Medical history
    Hypertension 11 (52) 29 (78) 9 (69)
    Diabetes 6 (29) 18 (49) 5 (38)
    Renal insufficiency 3 (14) 8 (22) 1 (8)
    Atrial fibrillation 2 (10) 14 (38) 4 (31)
    Stroke 2 (10) 4 (11) 1 (8)
    Previous PCI 3 (14) 14 (38) 5 (38)
Previous CABG 2 (10) 6 (16) 5 (38)
NYHA class, 1–4 scale 2.4 ± 0.8 2.4 ±0.8 2.7 ± 0.8
LVEF, % 65.2 ± 10.1 38.2 ± 14.7 32.3 ± 12.5§
IMR grade, 0–4 scale 0.3 ± 0.5 3.2 ± 0.7 3.3 ± 0.8§
Basal aneurysm/dyskinesis 0 (0) 1 (3) 7 (54), §
Inferior wall motion abnormality 0 (0) 32 (86) 10 (77)
LVEDD, cm 4.7 ± 0.8 5.7 ± 0.8 6.0 ± 1.0§
LVESD, cm 3.2 ± 0.8 4.6 ± 0.8 5.1 ± 1.2§
Annuloplasty ring
    Profile 3D ring - 23 (62) 12 (92)
    CE Physio II ring (Edwards Lifesciences, Irvine, Calif) - 7 (19) 1 (8)
    CG Future band (Medtronic, Minneapolis, Minn) - 6 (16) 0 (0)
    St Jude tailor flexible ring (St Jude Medical Inc, St Paul, Minn) - 1 (3) 0 (0)
Ring size, mm - 29.0 ±1.7 28.6 ± 1.3
Concomitant procedures
    CABG 6 (29) 25 (68) 8 (62)
    Aortic valve replacement 14 (67) 4 (11) 0 (0)§
    Tricuspid valve repair 0 (0) 4 (11) 2 (15)
    Atrial maze 0 (0) 7 (19) 0 (0)
    Atrial septal defect closure 1 (5) 0 (0) 0 (0)

IMR, Ischemic mitral regurgitation; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; 3D, 3-dimensional.

*

Data are presented as mean ± standard deviation or number (%).

P < .05 recurrent versus nonrecurrent.

P < .05 nonrecurrent versus normal.

§

P < .05 recurrent versus normal.